Location: New York, NY
CIK: 0001855655 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value: $1.294B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LEGN | LEGEND BIOTECH CORP | 1,805,717 | $125M | 9.6% | $48.56 | — | SPONSORED ADS | 52490G102 |
| INCY | INCYTE CORP | 1,381,711 | $86.01M | 6.6% | $74.99 | -10.9% | COM | 45337C102 |
| IMCR | IMMUNOCORE HLDGS PLC | 1,270,124 | $76.16M | 5.9% | $42.11 | — | ADS | 45258D105 |
| ACLX | ARCELLX INC | 2,347,000 | $74.21M | 5.7% | $29.54 | +29.4% | COMMON STOCK | 03940C100 |
| — | KARUNA THERAPEUTICS INC | 283,605 | $61.5M | 4.8% | $216.85 | — | COM | 48576A100 |
| — | CEREVEL THERAPEUTICS HLDNG I | 1,868,946 | $59.41M | 4.6% | $25.47 | — | COM | 15678U128 |
| ARGX | ARGENX SE | 150,000 | $58.46M | 4.5% | $375.49 | — | Put | 04016X101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,415,256 | $57.46M | 4.4% | $21.47 | +19.5% | COM | 92790C104 |
| ARGX | ARGENX SE | 142,259 | $55.44M | 4.3% | $375.49 | — | SPONSORED ADR | 04016X101 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 238,388 | $52.62M | 4.1% | $214.96 | +3.0% | COM | 91307C102 |
| — | MIRATI THERAPEUTICS INC | 1,443,762 | $52.16M | 4.0% | $62.92 | — | COM | 60468T105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,424,132 | $50.74M | 3.9% | $21.25 | -2.0% | COM | 87164F105 |
| BCYC | BICYCLE THERAPEUTICS PLC | 1,985,430 | $50.67M | 3.9% | $19.68 | — | SPONSORED ADS | 088786108 |
| NUVL | NUVALENT INC | 1,120,465 | $47.25M | 3.7% | $37.81 | 0.0% | COM | 670703107 |
| ONC | BEIGENE LTD | 216,093 | $38.53M | 3.0% | $210.00 | — | SPONSORED ADR | 07725L102 |
| XENE | XENON PHARMACEUTICALS INC | 989,327 | $38.09M | 2.9% | $37.90 | +4.9% | COM | 98420N105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 3,731,046 | $33.69M | 2.6% | $4.79 | +26.1% | COM | 68062P106 |
| — | AMBRX BIOPHARMA INC | 1,650,499 | $27.17M | 2.1% | $16.46 | — | SPONSORED ADS | 02290A102 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,395,002 | $25.14M | 1.9% | $19.24 | +3.6% | COM | 22663K107 |
| — | ALPINE IMMUNE SCIENCES INC | 2,423,961 | $24.92M | 1.9% | $7.85 | — | COM | 02083G100 |
| VIR | VIR BIOTECHNOLOGY INC | 1,014,239 | $24.88M | 1.9% | $25.11 | 0.0% | COM | 92764N102 |
| ZLAB | ZAI LAB LTD | 865,297 | $23.99M | 1.9% | $31.19 | — | ADR | 98887Q104 |
| IMTX | IMMATICS N.V | 1,984,813 | $22.9M | 1.8% | $9.33 | 0.0% | SHS | N44445109 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 9,217,150 | $21.94M | 1.7% | $2.38 | — | SPON ADS | 05280R100 |
| — | VOR BIOPHARMA INC | 6,461,467 | $19.97M | 1.5% | $6.84 | — | COM | 929033108 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 85,000 | $19.64M | 1.5% | $270.85 | 0.0% | COM | 558868105 |
| — | VERONA PHARMA PLC | 893,861 | $18.9M | 1.5% | $20.08 | — | SPONSORED ADS | 925050106 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 369,615 | $18.85M | 1.5% | $26.91 | 0.0% | CLASS A ORD | 61559X104 |
| — | THESEUS PHARMACEUTICALS INC | 1,950,327 | $18.2M | 1.4% | $8.98 | — | COM | 88369M101 |
| KURA | KURA ONCOLOGY INC | 1,004,908 | $10.63M | 0.8% | $11.83 | 0.0% | COM | 50127T109 |